Related Experiment Video
Updated: Mar 10, 2026
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast cell disorders: Kids are not just little people
Marti J Rothe1, Jane M Grant-Kels1, Hanspaul S Makkar1
1Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT.
Insights
Cutaneous mastocytosis presents differently in children and adults. Pediatric cases often resolve spontaneously, while adult cases may progress, necessitating age-specific management strategies.
Area of Science:
- Dermatology
- Hematology
- Pediatrics
Background:
- Cutaneous mastocytosis involves increased mast cells in the skin, potentially affecting other organs.
- Symptoms and disease severity depend on skin burden and extracutaneous involvement.
- Mast cell degranulation triggers various clinical manifestations.
Purpose of the Study:
- To highlight the distinct clinical presentations of pediatric versus adult cutaneous mastocytosis.
- To outline age-specific diagnostic and management approaches.
- To emphasize the importance of tailored treatment strategies based on patient age.
Main Methods:
- Comparative analysis of clinical data from pediatric and adult patients.
- Review of diagnostic workup protocols.
- Evaluation of current treatment guidelines.
Main Results:
- Pediatric cutaneous mastocytosis typically shows spontaneous remission by puberty.
- Adult-onset disease often progresses and has a higher risk of extracutaneous and hematologic involvement.
- Management strategies must account for these age-related differences.
Conclusions:
- Age at presentation is a critical factor in the prognosis and management of cutaneous mastocytosis.
- Pediatric management should not solely rely on adult-based protocols.
- Differentiated approaches are essential for optimal patient outcomes.
Abstract:
Cutaneous mastocytosis is characterized by a pathologic increase in mast cells in the skin and may also involve extracutaneous organs. Symptoms, which are triggered by mast cell degranulation, vary depending on the burden of skin disease and the presence of extracutaneous disease. The clinical presentation, risk of systemic disease, pathogenesis, prognosis, and treatment options differ, largely depending on age at presentation. In the pediatric population, spontaneous remission is typical, generally by puberty, whereas in adults, progression is observed. Extracutaneous involvement and associated hematologic disorders seldom occur in children, as opposed to adults. It is therefore important to avoid overreliance on adult-based approaches to management of cutaneous mastocytosis in the pediatric population. We focus on differences in presentation, workup, and management of pediatric- and adult-onset cutaneous mast cell disorders.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:27Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:15Differentiation of Common Myeloid Progenitor Cells
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
02:06Allergic Reactions